TCTC Holdings LLC Has $10.12 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

TCTC Holdings LLC cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.5% in the fourth quarter, Holdings Channel reports. The institutional investor owned 20,008 shares of the healthcare conglomerate’s stock after selling 312 shares during the period. TCTC Holdings LLC’s holdings in UnitedHealth Group were worth $10,121,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the company. Cibc World Markets Corp grew its holdings in shares of UnitedHealth Group by 4.2% during the fourth quarter. Cibc World Markets Corp now owns 418,371 shares of the healthcare conglomerate’s stock worth $211,637,000 after buying an additional 16,984 shares in the last quarter. Arbor Capital Management Inc. ADV grew its stake in UnitedHealth Group by 3.8% in the fourth quarter. Arbor Capital Management Inc. ADV now owns 2,484 shares of the healthcare conglomerate’s stock valued at $1,335,000 after purchasing an additional 91 shares in the last quarter. IMG Wealth Management Inc. bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $177,000. GLOBALT Investments LLC GA grew its stake in UnitedHealth Group by 45.6% in the fourth quarter. GLOBALT Investments LLC GA now owns 18,793 shares of the healthcare conglomerate’s stock valued at $9,507,000 after purchasing an additional 5,890 shares in the last quarter. Finally, Signature Wealth Management Group grew its stake in UnitedHealth Group by 2.7% in the fourth quarter. Signature Wealth Management Group now owns 3,724 shares of the healthcare conglomerate’s stock valued at $1,884,000 after purchasing an additional 97 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Up 1.5 %

Shares of UnitedHealth Group stock opened at $488.52 on Monday. The firm has a market capitalization of $446.85 billion, a PE ratio of 31.52, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm’s 50 day moving average is $511.36 and its 200 day moving average is $549.80. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period last year, the company earned $5.83 EPS. The firm’s revenue was up 6.8% compared to the same quarter last year. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.72%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have weighed in on the company. Barclays decreased their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a research note on Friday, January 10th. Finally, Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.